Xeris Biopharma Holdings, Inc. Quarterly Current Ratio in % from Q2 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Xeris Biopharma Holdings, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q2 2024.
  • Xeris Biopharma Holdings, Inc. Current Ratio for the quarter ending June 30, 2024 was 199 %, a 8.19% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 199 -17.7 -8.19% Jun 30, 2024
Q1 2024 192 -37.9 -16.5% Mar 31, 2024
Q4 2023 185 -61.8 -25% Dec 31, 2023
Q3 2023 207 -19.2 -8.48% Sep 30, 2023
Q2 2023 217 -28.2 -11.5% Jun 30, 2023
Q1 2023 230 Mar 31, 2023
Q4 2022 247 Dec 31, 2022
Q3 2022 226 Sep 30, 2022
Q2 2022 245 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.